Apixaban to Prevent Venous Thromboembolism in Patients with Cancer | New England Journal of Medicine | 2019 | 391 |
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy | Annals of Oncology | 2008 | 131 |
A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7 | British Journal of Haematology | 2007 | 73 |
Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy | BMC Cancer | 2008 | 71 |
Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14 | Journal of Clinical Oncology | 2011 | 70 |
Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation | Journal of Clinical Medicine | 2016 | 60 |
Thrombocytosis as a prognostic marker in gastrointestinal cancers | World Journal of Gastrointestinal Oncology | 2014 | 46 |
Proteasome expression and activity in cancer and cancer stem cells | Tumor Biology | 2017 | 41 |
The chemosensitivity of testicular germ cell tumors | Cellular Oncology (Dordrecht) | 2014 | 31 |
Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment Considerations | Clinical Medicine Insights: Oncology | 2016 | 30 |
Immune Blockade Inhibition in Breast Cancer | Anticancer Research | 2016 | 27 |
PD-1 inhibitors monotherapy in hepatocellular carcinoma: Meta-analysis and systematic review | Hepatobiliary and Pancreatic Diseases International | 2019 | 21 |
High Tumor Mutation Burden and Other Immunotherapy Response Predictors in Breast Cancers: Associations and Therapeutic Opportunities | Targeted Oncology | 2020 | 18 |
Expression and function of immune ligand-receptor pairs in NK cells and cancer stem cells: therapeutic implications | Cellular Oncology (Dordrecht) | 2018 | 17 |
The network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancer | Breast Cancer: Targets and Therapy | 2015 | 17 |
Diabetes, Obesity, and the Metabolic Syndrome as Prognostic Factors in Stages I to III Colorectal Cancer Patients | Journal of Gastrointestinal Cancer | 2019 | 17 |
A systematic review and pooled analysis of retrospective series of eribulin in metastatic breast cancer | Anti-Cancer Drugs | 2017 | 15 |
Obesity and diabetes as prognostic factors in patients with colorectal cancer | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2017 | 13 |
Prediction of Oncotype Dx recurrence score using clinical parameters: A comparison of available tools and a simple predictor based on grade and progesterone receptor | Hematology/ Oncology and Stem Cell Therapy | 2019 | 13 |
Pluripotency transcription factors in the pathogenesis of colorectal cancer and implications for prognosis | Biomarkers in Medicine | 2015 | 13 |
Negative-pressure wound therapy after fasciotomy reduces muscle-fiber regeneration in a pig model | Journal of Bone and Joint Surgery - Series A | 2014 | 13 |
Vitamin D baseline levels at diagnosis of breast cancer: A systematic review and meta-analysis | Hematology/ Oncology and Stem Cell Therapy | 2021 | 12 |
Recommendation for omitting axillary lymph node dissection should be individualized in patients with breast cancer with one or two positive sentinel lymph nodes | Journal of Clinical Oncology | 2014 | 11 |
Major Outcomes With Personalized Dialysate TEMPerature (MyTEMP): Rationale and Design of a Pragmatic, Registry-Based, Cluster Randomized Controlled Trial | Canadian Journal of Kidney Health and Disease | 2020 | 10 |
Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma | World Journal of Gastrointestinal Oncology | 2017 | 10 |